--------------------------------------------------------------------------------

EXHIBIT 10.1
 
SUBSCRIPTION AGREEMENT

Applied DNA Sciences, Inc.
25 Health Sciences Drive, Suite 113
Stony Brook, New York 11790

Gentlemen and Ladies:

The undersigned (the “Subscriber”) hereby subscribes for ________ unit(s) (the
“Units”), at a price of $50,000 per Unit, each consisting of (i) a $50,000
principal amount 10% Secured Convertible Promissory Note (each a “Note,” or
collectively, the “Notes”) of Applied DNA Sciences, Inc., a Nevada corporation
(the “Company”), and (ii) a warrant to purchase 100,000 shares of common stock
of the Company (each a “Warrant,” or collectively, the “Warrants”), exercisable
for a period of four years commencing on the first anniversary of the date of
the closing of the first purchase and sale of such Units (the “Closing Date”) at
a price of $0.50 per share. These Units are part of an offering of up to forty
such Units by the Company to one or more subscribers (the "Offering"). Each
Warrant may be redeemed at the option of the Company at a redemption price of
$0.01 upon the earlier of (i) the date three years from issuance and (ii) the
date the Company’s stock has traded on The Over the Counter Bulletin Board or a
national securities exchange at or above $1.00 per share for 20 consecutive
trading days. The Notes and accrued but unpaid interest thereon are convertible
into shares of common stock of the Company at a price of $0.50 per share by the
holder of the Notes at any time from their date of issuance through the first
anniversary of such date and shall automatically convert on such anniversary at
a 20% discount to the average volume weighted average price of the Company’s
common stock for the ten trading days prior to the Closing Date. In addition, at
any time prior to conversion, the Company will have the right to prepay the
Notes and accrued but unpaid interest thereon upon 3 days notice, such notice to
allow the holders of the Notes to convert the Notes into shares of common stock
of the Company prior to such repayment.
 
Until the principal and interest owed under the Notes are paid in full, or
converted into common stock of the Company, the Notes will be secured by a
security interest in all of the assets of the Company. This security interest
will be pari passu with the security interest granted to the holders of
$1,500,000 of $50,000 principal amount secured convertible promissory notes of
the Company, bearing interest at 10% per annum issued as part of an offering
completed on March 8, 2006 (the “March Notes”) and the holders of $2,950,000 of
$50,000 principal amount secured convertible promissory notes of the Company,
bearing interest at 10% per annum issued as part of offerings completed on May
2, 2006 and June 15, 2006 (the “May and June Notes”). The Company may issue up
to $20,000,000 of debt in addition to the amounts sold in the offering that may
be secured by a security interest in all of the Company’s assets, which would be
pari passu to the security interest granted to the holders of the Notes, the May
and June Notes, and the March Notes.
 
The Notes bear interest at the rate of 10% per annum. All principal and all
accrued and unpaid interest under the Notes shall be payable in full on the date
12-months subsequent to the Closing Date, referred to hereinafter as the
“Maturity Date.”
 
1.  Subscription. Subject to the terms and conditions hereof, the Subscriber
agrees to pay $__________________ by check or wire transfer of immediately
available funds as consideration for the Subscriber’s Note(s) and the
Warrant(s). The Subscriber tenders herewith a check made payable at the
direction of the Company or wire transfer, in the amount of $__________________.
The Subscriber acknowledges and agrees that this subscription is irrevocable by
the Subscriber but is subject to acceptance by the Company.

2.  Security. Until the principal and interest owed under the Notes are paid in
full, or converted into common stock of the Company, the Notes will be secured
by a security interest in all of the assets of the Company. This security
interest will be pari passu with the security interest granted to the holders of
$1,500,000 of $50,000 principal amount secured convertible promissory notes of
the Company, bearing interest at 10% per annum issued as part of an offering
completed on March 8, 2006 (the “March Notes”) and the holders of $2,950,000 of
$50,000 principal amount secured convertible promissory notes of the Company,
bearing interest at 10% per annum issued as part of offerings completed on May
2, 2006 and June 15, 2006 (the “May and June Notes”). The Company may issue up
to $8,050,000 of debt in addition to the amounts sold in the offering that may
be secured by a security interest in all of the Company’s assets, which would be
pari passu to the security interest granted to the holders of the Notes, the May
and June Notes, and the March Notes.
 
1

--------------------------------------------------------------------------------

3.  Closing. The Subscriber understands and agrees that the Company intends to
make an initial closing of this offering of Units in the Company on or before
June 30, 2007, but that the same may be extended for three additional periods,
each such period not to exceed thirty (30) days, at the sole decision of the
Company, without notice to any Subscriber. If the Company does not accept the
Subscriber prior to Closing Date, this Subscription Agreement and Confidential
Offering Questionnaire, together with the Subscriber’s funds and any other
documents delivered to the Company, shall be promptly returned to the
Subscriber.

4.  Subscription Compliance. The Subscriber agrees that this subscription is
subject to the following terms and conditions:

The Company shall have the right, in its sole discretion, to: (i) accept or
reject this subscription; (ii) determine whether this Subscription Agreement has
been properly completed by the Subscriber and (iii) determine whether the
Subscriber has met all of the Company’s requirements for investment in a Unit.
If the Company deems this subscription to be defective, deficient or otherwise
non-compliant with the terms of this offering, the Subscriber’s funds will be
returned promptly to the Subscriber without interest or deduction.

5.  Receipt of Information.

a.  The Subscriber and Subscriber’s purchaser representative, if any, have
received a copy of the Confidential Private Placement Term Sheet. The
Subscriber, either alone or together with Subscriber’s purchaser representative,
if any, have such knowledge and experience in financial and business matters as
to be able to evaluate the merits and risks of an investment in the Company.

b.  The Subscriber and Subscriber’s representative, if any, have had the
opportunity to ask questions of and receive answers from the Company concerning
the terms and conditions of the offering of the Units by the Company and to
obtain any additional information Subscriber has requested which is necessary to
verify the accuracy of the information furnished to the Subscriber concerning
the Company and such offering.

6.   Representations of Subscriber. In connection with the purchase of the
Units, the Subscriber hereby represents and warrants to the Company as follows:

a.  If the Subscriber is an individual purchaser of the Unit(s), the Subscriber
represents and warrants that he/she is at least 25 years of age and a resident
of the Country of _______________ and is not nor has ever been a “U.S. person,”
as defined in Rule 902 promulgated under the Securities Act of 1933, as amended
(the “Act”).

b.  If the Subscriber is a Company, trust or other corporate entity purchaser of
the Unit(s), the Subscriber represents and warrants that it is duly organized
and validly existing under the laws of the Country of _______________, and has
all requisite powers to purchase the Unit(s). If the subscriber is a trust, none
of the trustees are a “U.S. person,” as defined in Rule 902 promulgated under
the Act.
 
2

--------------------------------------------------------------------------------

c.  The Subscriber is an “accredited investor” as defined in Rule 501 of
Regulation D promulgated under the Act.

d.  The Unit(s) is being purchased for the Subscriber’s own account without the
participation of any other person, with the intent of holding the Unit(s) for
investment and without the intent of participating, directly or indirectly, in a
distribution of the Unit(s) and not with a view to, or for a resale in
connection with, any distribution of the Unit(s) or any portion thereof, nor is
the undersigned aware of the existence of any distribution of the Company’s
securities. Furthermore, the undersigned has no present intention of dividing
such Unit(s) with others or reselling or otherwise disposing of any portion of
such Unit(s), either currently or after the passage of a fixed or determinable
period of time, or upon the occurrence or nonoccurrence of any predetermined
event or circumstance.

e.  The Subscriber has no need for liquidity with respect to his purchase of a
Unit(s) and is able to bear the economic risk of an investment in the Unit(s)
for an indefinite period of time and is further able to afford a complete loss
of such investment.

f.  The Subscriber represents that his financial commitment to all investments
(including his investment in the Company) is reasonable relative to his net
worth and liquid net worth.

g.  The Subscriber recognizes that the Unit(s) will be: (i) sold to the
Subscriber without registration under any United States federal or other law
relating to the registration of securities for sale; (ii) issued and sold in
reliance on the exemption from registration under the Nevada Securities Act, as
amended (the “Nevada Act”); and (iii) issued and sold to non-United States
persons, as defined in Rule 902(k) promulgated under the Act.

h.  The Subscriber is aware that any resale of the Unit(s) cannot be made except
in accordance with the registration requirements of the Act or an exemption
therefrom.

i.  The Subscriber represents and warrants that all offers and sales of the
Unit(s) shall be made pursuant to an exemption from registration under the Act
or pursuant to registration under the Act, and the Subscriber will not engage in
any hedging or short selling transactions with regard to the Unit(s) or the
underlying common stock.

j.  The Subscriber is not acquiring the Unit(s) based upon any representation,
oral or written, by any person with respect to the future value of, or income
from, the Unit(s) but rather upon an independent examination and judgment as to
the prospects of the Company.

k.  The Subscriber understands that the Company is an early stage Company and
has a minimal operating history. The Subscriber appreciates and understands the
risks involved with investing in a Company with a limited operating history and
has read and understands the risk factors set forth in the Confidential Private
Placement Term Sheet and in the Company’s Annual Report on Form 10-KSB, filed on
January 16, 2007, and in its subsequent quarterly report on Form 10-QSB, and
current reports on Form 8-K. Copies of such material are attached to the Term
Sheet and can be obtained by visiting the Securities and Exchange Commission’s
website at http://www.sec.gov.

l.  The Company, by and through itself and/or legal counsel, has made no
representations or warranties as to the suitability of the Subscriber’s
investment in the Company, the length of time the undersigned will be required
to own the Unit(s), or the profit to be realized, if any, as a result of
investment in the Company. Neither the Company nor its counsel has made an
independent investigation on behalf of the Subscriber, nor has the Company, by
and through itself and counsel, acted in any advisory capacity to the
Subscriber.
 
3

--------------------------------------------------------------------------------

m.  The Company, by and through itself and/or legal counsel, has made no
representations or warranties that the past performance or experience on the
part of the Company, or any partner or affiliate, their partners, salesmen,
associates, agents, or employees or of any other person, will in any way
indicate the predicted results of the ownership of the Unit(s).

n.  The Company has made available for inspection by the undersigned, and his
purchaser representative, if any, the books and records of the Company. Upon
reasonable notice, such books and records will continue to be made available for
inspection by investors upon reasonable notice during normal business hours at
the principal place of business of the Company.

o.  The Unit(s) was not offered to the Subscriber by means of publicly
disseminated advertisement or sales literature, nor is the Subscriber aware of
any offers made to other persons by such means.

p.  All information which the Subscriber has provided to the Company concerning
the Subscriber is correct and complete as of the date set forth at the end of
this Subscription Agreement, and if there should be any material adverse change
in such information prior to receiving notification that this subscription has
been accepted, the undersigned will immediately provide the Company with such
information.

7.    Agreements of Subscriber. The Subscriber agrees as follows:

a.    The sale of the Unit(s) by the Company has not been recommended by any
United States federal or other securities commission or regulatory authority.
Furthermore, the foregoing authorities have not confirmed the accuracy or
determined the adequacy of this Subscription Agreement or the Confidential
Private Placement Term Sheet.

b.    The Unit(s) and the underlying common stock will not be offered for sale,
sold, or transferred other than pursuant to: (i) an effective registration under
the Nevada Act or in a transaction which is otherwise in compliance with the
Nevada Act; (ii) an effective registration under the Act or in a transaction
otherwise in compliance with the Act; and (iii) evidence satisfactory to the
Company of compliance with the applicable securities laws of other
jurisdictions. The Company shall be entitled to rely upon an opinion of counsel
satisfactory to it with respect to compliance with the above laws.

c.    The Company is under no obligation to register the Unit(s) or to comply
with any exemption available for sale of the Unit(s) without registration, and
the information necessary to permit routine sales of securities of the Company
under Rule 144 of the Act may not be available when you desire to resell them
pursuant to Rule 144 of the Act. The Company is under no obligation to act in
any manner so as to make Rule 144 available with respect to the Unit(s).

d.    There is no established market for the Units and it is not anticipated
that any public market for the Units will develop in the future.

e.    The Company may, if it so desires, refuse to permit the transfer of the
Unit(s) unless the request for transfer is accompanied by an opinion of counsel
acceptable to the Company to the effect that neither the sale nor the proposed
transfer will result in any violation of the Act or the applicable securities
laws of any other jurisdiction.

f.    A legend indicating that the Unit(s) and the underlying common stock have
not been registered under such securities laws and referring to the restrictions
and transferability of Unit(s) and the underlying common stock may be placed on
the certificates or instruments delivered to the Subscriber or any substitutes
thereof and any transfer agent of the Company may be instructed to require
compliance therewith.
 
4

--------------------------------------------------------------------------------

8.    Indemnification of the Company. The undersigned understands the meaning
and legal consequences of the representations and warranties contained herein,
and hereby agrees to indemnify and hold harmless, the Company, its respective
agents, officers, managers and affiliates from and against any and all damages,
losses, costs and expenses (including reasonable attorneys’ fees) which they or
any of them may incur by reason of the failure of the Subscriber to fulfill any
of the terms of this Subscription Agreement, or by reason of any breach of the
representations and warranties made by the Subscriber herein, or in any document
provided by the Subscriber to the Company.

9.    Representative Capacity. If an investment in the Company is being made by
a corporation, trust or estate, the undersigned individual signing on behalf of
the Subscriber, represents that he has all right and authority, in his capacity
as an officer, managing member, trustee, executor or other representative of
such corporation, trust or estate, as the case may be, to make such decision to
invest in the Company and to execute and deliver this Subscription Agreement on
behalf of such corporation, trust or estate as the case may be, enforceable in
accordance with its terms. The undersigned individual also represent that any
such corporation, trust or estate was not formed for the purpose of buying the
Unit(s) hereby subscribed.
 
10.    Special Power of Attorney.

 a.    The Subscriber, by executing this Subscription Agreement, irrevocably
makes, constitutes and appoints any executive officer of the Company, and each
of them individually, as the undersigned’s true and lawful attorney, for the
undersigned and in the undersigned’s name, place and stead, and for the use and
benefit of the undersigned, to execute and acknowledge and, to the extent
necessary, to file and record:

1.  such certificates, instruments and documents as may be required to be filed
by the Company or which the Company deems advisable to file under the laws of
the State of Nevada or any other state or jurisdiction in which the Company
transacts business; and
 
2.  all conveyances or other instruments or documents necessary, appropriate or
convenient to effect the dissolution and termination of the Company.

b.    Such a power of attorney:

1.  is a special power of attorney coupled with an interest and is irrevocable;
and;
 
2.  shall survive the death or disability of the Subscriber.

c.    The Subscriber hereby agrees to be bound by any representations made by
the Company or its substitutes acting pursuant to this Special Power of
Attorney, and the undersigned hereby waives any and all defenses which may be
available to him to contest, negate or disaffirm its actions or the actions of
his substitutes under this Special Power of Attorney. The powers herein granted
are granted for the sole and exclusive benefit of the undersigned and not on
behalf of any other person, in whole or in part.

5

--------------------------------------------------------------------------------

 
11.    Subscription Not Revocable. The undersigned hereby acknowledges and
agrees that the undersigned is not entitled to cancel, terminate or revoke this
Subscription Agreement or any agreements of the undersigned hereunder and that
this Subscription Agreement shall survive the dissolution, death or disability
of the undersigned.

12.    Restrictions on Transferability. The undersigned understands and agrees
that the Unit(s) shall not be sold, pledged, hypothecated or otherwise
transferred unless the Unit(s) is registered under the Act and applicable state
securities laws or an exemption from such registration is available.

13.    Governing Law. This Subscription Agreement is being delivered and is
intended to be performed in the State of New York, and shall be construed and
enforced in accordance with, and the law of such state shall govern the rights
of parties.

14.    Numbers and Gender. In this Agreement, the masculine gender includes the
feminine gender and the neuter and the singular includes the plural, where
appropriate to the context.

THIS SPACE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS

6

--------------------------------------------------------------------------------

APPLIED DNA SCIENCES , INC.
SIGNATURE PAGE TO
SUBSCRIPTION AGREEMENT

Subscriber hereby elects to subscribe under the Subscription Agreement for a
total of $______________ Units (NOTE: to be completed by subscriber) and
executes the Subscription Agreement.

IN WITNESS WHEREOF, the undersigned has executed this Subscription Agreement on
the date set forth below.

Date of Execution: June __, 2007

IF INDIVIDUAL INVESTOR:

 

--------------------------------------------------------------------------------

(Signature)

 

--------------------------------------------------------------------------------

(Printed Name)

IF CORPORATION, TRUST,
ESTATE OR REPRESENTATIVE: 
 
 

--------------------------------------------------------------------------------

Name of Investor
 
 
 
By:

--------------------------------------------------------------------------------

Name: 
Title:

 
(Investors do not write below this line)

--------------------------------------------------------------------------------

 
APPROVED THIS ____ DAY OF JUNE, 2007 

APPLIED DNA SCIENCES, INC.

By: ______________________________      
Name:
Title:
 
 
 
 
 
7